Overview
Onepot AI has raised $13 million to simplify chemical drug creation, addressing the challenge of synthesizing new molecules that hinder drug discovery. The company was founded by Daniil Boiko and Andrei Tyrin, who aim to accelerate the drug development process. Key investors were not mentioned in the article.
Products
Loading...
Recent Deals
Onepot AI has raised $13 million to simplify chemical drug creation, addressing the challenge of synthesizing new molecules that hinder drug discovery. The company was founded by Daniil Boiko and Andrei Tyrin, who aim to accelerate the drug development process. Key investors were not mentioned in the article.